Rejuvera Healer – Advanced Skin Repair Mesotherapy
REJUVERA HEALER is a professional mesotherapy solution formulated to promote skin repair, regeneration, hydration, and cellular recovery.
Developed with a rich blend of amino acids, peptides, antioxidants, vitamins, and hyaluronic acid, it restores compromised skin, enhances vitality, and supports post-treatment healing.
Key Benefits
- Accelerates skin repair and regeneration
- Improves hydration and strengthens the skin barrier
- Reduces redness and enhances recovery after aesthetic procedures
- Boosts collagen production with peptides and amino acids
- Brightens the complexion with niacinamide and antioxidants
- Supports cellular energy and tissue healing
Active Ingredients
Based on the official technical data sheet :contentReference[oaicite:2]{index=2}
- Sodium Hyaluronate – Hydration & moisture balance
- Succinic Acid – Cellular energy & skin revitalization
- Sodium DNA – Healing & tissue regeneration
- Niacinamide – Brightening & barrier support
- Ascorbyl Glucoside + Ascorbic Acid – Antioxidant & radiance
- Hydrolyzed Collagen – Elasticity & firmness
- Amino Acids Complex – Lysine, Proline, Glycine, Histidine, Isoleucine, etc. – Structural support & collagen synthesis
- Glutathione & Acetyl Cysteine – Detoxifying & whitening effect
- Biotin, Riboflavin, Cyanocobalamin, Folic Acid – Vitamin complex for cellular repair
- Copper Tripeptide-1 – Wound healing & anti-inflammatory action
Professional Use
- Post-laser & post-peeling skin recovery
- Damaged, irritated, and stressed skin
- Anti-aging supportive treatments
- Restoration of moisture, elasticity, and vitality
Formulation Quality
According to the laboratory specifications:
- pH: 6.30 – 8.30
- Density: 0.95 g/mL ± 0.1 g/mL
- Appearance: Colorless to pale yellow, limpid to slightly turbid
- Osmolality: 200 – 700 mOsm/kg
- Total microbial count: ≤ 10³ CFU/mL – PASS
- Yeast & mold: ≤ 10² CFU/mL – PASS
Formulated in Switzerland – manufactured in Italy.









3 reviews for REJUVERA HEALER
There are no reviews yet.